<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05071976</url>
  </required_header>
  <id_info>
    <org_study_id>21-349</org_study_id>
    <nct_id>NCT05071976</nct_id>
  </id_info>
  <brief_title>A Study of Near-Infrared Fluorescence Imaging With ICG During Reconstructive Gynecologic Surgery</brief_title>
  <official_title>Near-infrared FluORescencE Assessment of Myocutaneous Flap Microperfusion for Gynecologic RecONstrucTion (FOREFRONT): A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to assess whether Near-Infrared Fluorescence/NIR Imaging&#xD;
      perfusion alters intraoperative management of the flap or of the participant wound bed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 24, 2021</start_date>
  <completion_date type="Anticipated">September 24, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 24, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of cases in which intraoperative ICG-NIR angiography altered surgical flap reconstruction plans</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>The primary purpose of this study is to introduce ICG-NIR angiography in abdominopelvic skin and myocutaneous pedicle flap-based reconstruction during gynecologic oncology surgery and determine the percentage of cases in which intraoperative ICG-NIR angiography altered surgical flap reconstruction plans.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Gynecologic Surgery</condition>
  <arm_group>
    <arm_group_label>Participants undergoing a pelvic or abdominal wall reconstruction procedure</arm_group_label>
    <description>Women undergoing a pelvic or abdominal wall reconstruction procedure after radical gynecologic surgery for any indication at Memorial Sloan Kettering Cancer Center</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ICG-NIR angiography</intervention_name>
    <description>Capture NIR video of flap site beginning at time of ICG injection. At time of subjective peak intensity, capture video of flap and recipient wound bed. Measure rate of ICG egress from the global flap at 60, 120, and 180 seconds after initial dye injection from intraoperative video</description>
    <arm_group_label>Participants undergoing a pelvic or abdominal wall reconstruction procedure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A member of the patient's treatment team, the protocol investigator, or a member of the&#xD;
        research team at MSK will identify potential research subjects. If the investigator is a&#xD;
        member of the treatment team, s/he will screen their patient's medical records for suitable&#xD;
        research study participants and discuss the study and their potential for enrolling in the&#xD;
        research study. Potential subjects contacted by their treating physician will be referred&#xD;
        to the investigator/research staff of the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women undergoing a pelvic reconstruction procedure after radical gynecologic surgery&#xD;
             for any indication at MSK.&#xD;
&#xD;
          -  Age â‰¥18 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women with hepatic dysfunction as evidenced by elevated transaminases (two times the&#xD;
             upper limit of normal).&#xD;
&#xD;
          -  Women with a history of cirrhosis or other chronic liver disease.&#xD;
&#xD;
          -  Women with a documented severe or life threatening allergy to iodine.&#xD;
&#xD;
          -  Women with an allergy to ICG or severe allergy to iodinated contrast.&#xD;
&#xD;
          -  Women undergoing any free flap (non-pedicled) reconstruction.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadeem Abu-Rustum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nadeem Abu-Rustum, MD</last_name>
    <phone>212-639-7051</phone>
    <email>abu-rusn@MSKCC.ORG</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Babak Mehrara, MD</last_name>
    <phone>646-608-8085</phone>
    <email>mehrarab@MSKCC.ORG</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Memoral Sloan Kettering Basking Ridge (Consent and Followup)</name>
      <address>
        <city>Basking Ridge</city>
        <state>New Jersey</state>
        <zip>07920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadeem Abu-Rustum, MD</last_name>
      <phone>212-639-7051</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Monmouth (Consent and Followup)</name>
      <address>
        <city>Middletown</city>
        <state>New Jersey</state>
        <zip>07748</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadeem Abu-Rustum, MD</last_name>
      <phone>212-639-7051</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Bergen (Consent and Followup)</name>
      <address>
        <city>Montvale</city>
        <state>New Jersey</state>
        <zip>07645</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadeem Abu-Rustum, MD</last_name>
      <phone>212-639-7051</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Suffolk - Commack (Consent and Followup)</name>
      <address>
        <city>Commack</city>
        <state>New York</state>
        <zip>11725</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadeem Abu-Rustum, MD</last_name>
      <phone>212-639-7051</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Westchester (Consent and Followup)</name>
      <address>
        <city>Harrison</city>
        <state>New York</state>
        <zip>10604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadeem Abu-Rustum, MD</last_name>
      <phone>212-639-7051</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadeem Abu-Rustum, MD</last_name>
      <phone>212-639-7051</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Nassau (Consent and Followup)</name>
      <address>
        <city>Rockville Centre</city>
        <state>New York</state>
        <zip>11553</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadeem Abu-Rustum, MD</last_name>
      <phone>212-639-7051</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskc.org</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 28, 2021</study_first_submitted>
  <study_first_submitted_qc>September 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gynecologic surgery</keyword>
  <keyword>abdominal wall reconstruction procedure</keyword>
  <keyword>pelvic reconstruction procedure</keyword>
  <keyword>Near-Infrared Fluorescence Imaging</keyword>
  <keyword>ICG</keyword>
  <keyword>21-349</keyword>
  <keyword>Memorial Sloan Kettering Cancer Center</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

